Related Experiment Videos

Monoclonal antibodies: the good, the bad, and the ugly

¹Rush-Presbyterian-St. Luke's Medical Center, Section of Bone Marrow Transplant and Cell Therapy, Chicago IL 60612, USA Han_Myint@rush.edu.

Journal of Hematotherapy & Stem Cell Research

|March 29, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression.

Journal of immunology (Baltimore, Md. : 1950)·2025

LAIR-1 agonism as a therapy for acute myeloid leukemia.

The Journal of clinical investigation·2023

Quantitative, Spatially Defined Expression of Leukocyte-associated Immunoglobulin-like Receptor in Non-small Cell Lung Cancer.

Cancer research communications·2023

AIM Platform: A Novel Nano Artificial Antigen-Presenting Cell-Based Clinical System Designed to Consistently Produce Multi-Antigen-Specific T-Cell Products with Potent and Durable Anti-Tumor Properties.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2021

Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high-risk MDS.

British journal of haematology·2015

Minimal change disease in graft versus host disease: a podocyte response to the graft?

Clinical nephrology·2012

See all related articles